HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Persistence of mutant isocitrate dehydrogenase in patients with acute myeloid leukemia in remission.

AuthorsW-C Chou, K-Y Peng, W-C Lei, B-S Ko, W Tsay, C-H Kuo, H-F Tien
JournalLeukemia (Leukemia) Vol. 26 Issue 3 Pg. 527-9 (Mar 2012) ISSN: 1476-5551 [Electronic] England
PMID21844873 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Nuclear Proteins
  • Nucleophosmin
  • Isocitrate Dehydrogenase
Topics
  • Base Sequence
  • Bone Marrow Cells (metabolism, pathology)
  • Humans
  • Isocitrate Dehydrogenase (genetics)
  • Leukemia, Myeloid, Acute (drug therapy, genetics)
  • Mutation
  • Nuclear Proteins (genetics)
  • Nucleophosmin
  • Remission Induction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: